India has approved Eli Lilly’s donanemab for patients with mild cognitive impairment or mild Alzheimer’s disease, but experts warn of high costs and access barriers. The drug has shown promising results in clinical trials, slowing cognitive and functional decline by around 35%. However, its real-world impact may be limited by its premium price tag.
India is on the cusp of a Blue Economy moment, with the country set to showcase its top 120 deep-tech ventures at Bharat Innovates 2026 in Nice, France. This initiative marks a significant shift from being a technology market to a technology builder, with a focus on sustainable use of ocean resources and protection of the marine environment.
Ola Electric’s recent stock surge is driven by expanding product portfolio, improving operational efficiency, and growing demand for electric vehicles in India. The company’s growth prospects are expected to be driven by increasing demand for electric vehicles and its commitment to innovation.
BlueStone and ideaForge have seen significant gains in their stock prices, driven by strong financial performance, growing customer base, and innovative products and services. This has had a positive impact on the overall market, with the NIFTY 50 index seeing a gain of 1.5% over the past week.
